540686 Stock Overview
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India.
Notes are coming soon
Smruthi Organics Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹162.25|
|52 Week High||₹311.00|
|52 Week Low||₹145.20|
|1 Month Change||-5.20%|
|3 Month Change||-23.88%|
|1 Year Change||-44.26%|
|3 Year Change||302.11%|
|5 Year Change||469.30%|
|Change since IPO||179.58%|
Recent News & Updates
|540686||IN Pharmaceuticals||IN Market|
Return vs Industry: 540686 underperformed the Indian Pharmaceuticals industry which returned -7.6% over the past year.
Return vs Market: 540686 underperformed the Indian Market which returned -2.2% over the past year.
|540686 Average Weekly Movement||6.0%|
|Pharmaceuticals Industry Average Movement||4.7%|
|Market Average Movement||5.7%|
|10% most volatile stocks in IN Market||9.0%|
|10% least volatile stocks in IN Market||3.3%|
Stable Share Price: 540686 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 540686's weekly volatility (6%) has been stable over the past year.
About the Company
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India. It API products include amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan for cardiovascular; metformin HCL, teneligliptin, dapagliflozin, and vildagliptin for anti-diabetic; ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate for anti-infective applications; and ticagrelor for anti-platelets. The company also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine, as well as bulk drugs.
Smruthi Organics Limited Fundamentals Summary
|540686 fundamental statistics|
Is 540686 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|540686 income statement (TTM)|
|Cost of Revenue||₹898.89m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 09, 2023
|Earnings per share (EPS)||7.13|
|Net Profit Margin||5.66%|
How did 540686 perform over the long term?See historical performance and comparison